Cargando…

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lennartz, Frank, Brod, Florian, Dabbs, Rebecca, Miura, Kazutoyo, Mekhaiel, David, Marini, Arianna, Jore, Matthijs M., Søgaard, Max M., Jørgensen, Thomas, de Jongh, Willem A., Sauerwein, Robert W., Long, Carole A., Biswas, Sumi, Higgins, Matthew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148045/
https://www.ncbi.nlm.nih.gov/pubmed/30237518
http://dx.doi.org/10.1038/s41467-018-06340-9
_version_ 1783356686738653184
author Lennartz, Frank
Brod, Florian
Dabbs, Rebecca
Miura, Kazutoyo
Mekhaiel, David
Marini, Arianna
Jore, Matthijs M.
Søgaard, Max M.
Jørgensen, Thomas
de Jongh, Willem A.
Sauerwein, Robert W.
Long, Carole A.
Biswas, Sumi
Higgins, Matthew K.
author_facet Lennartz, Frank
Brod, Florian
Dabbs, Rebecca
Miura, Kazutoyo
Mekhaiel, David
Marini, Arianna
Jore, Matthijs M.
Søgaard, Max M.
Jørgensen, Thomas
de Jongh, Willem A.
Sauerwein, Robert W.
Long, Carole A.
Biswas, Sumi
Higgins, Matthew K.
author_sort Lennartz, Frank
collection PubMed
description The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infected humans, thereby stopping the transmission cycle. One of the most promising targets for such a vaccine is the gamete surface protein, Pfs48/45. Here we establish a system for production of full-length Pfs48/45 and use this to raise a panel of monoclonal antibodies. We map the binding regions of these antibodies on Pfs48/45 and correlate the location of their epitopes with their transmission-blocking activity. Finally, we present the structure of the C-terminal domain of Pfs48/45 bound to the most potent transmission-blocking antibody, and provide key molecular information for future structure-guided immunogen design.
format Online
Article
Text
id pubmed-6148045
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61480452018-09-25 Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody Lennartz, Frank Brod, Florian Dabbs, Rebecca Miura, Kazutoyo Mekhaiel, David Marini, Arianna Jore, Matthijs M. Søgaard, Max M. Jørgensen, Thomas de Jongh, Willem A. Sauerwein, Robert W. Long, Carole A. Biswas, Sumi Higgins, Matthew K. Nat Commun Article The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An approach with great potential is a transmission-blocking vaccine which induces antibodies that prevent establishment of a productive infection in mosquitos that feed on infected humans, thereby stopping the transmission cycle. One of the most promising targets for such a vaccine is the gamete surface protein, Pfs48/45. Here we establish a system for production of full-length Pfs48/45 and use this to raise a panel of monoclonal antibodies. We map the binding regions of these antibodies on Pfs48/45 and correlate the location of their epitopes with their transmission-blocking activity. Finally, we present the structure of the C-terminal domain of Pfs48/45 bound to the most potent transmission-blocking antibody, and provide key molecular information for future structure-guided immunogen design. Nature Publishing Group UK 2018-09-20 /pmc/articles/PMC6148045/ /pubmed/30237518 http://dx.doi.org/10.1038/s41467-018-06340-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lennartz, Frank
Brod, Florian
Dabbs, Rebecca
Miura, Kazutoyo
Mekhaiel, David
Marini, Arianna
Jore, Matthijs M.
Søgaard, Max M.
Jørgensen, Thomas
de Jongh, Willem A.
Sauerwein, Robert W.
Long, Carole A.
Biswas, Sumi
Higgins, Matthew K.
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title_full Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title_fullStr Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title_full_unstemmed Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title_short Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
title_sort structural basis for recognition of the malaria vaccine candidate pfs48/45 by a transmission blocking antibody
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148045/
https://www.ncbi.nlm.nih.gov/pubmed/30237518
http://dx.doi.org/10.1038/s41467-018-06340-9
work_keys_str_mv AT lennartzfrank structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT brodflorian structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT dabbsrebecca structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT miurakazutoyo structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT mekhaieldavid structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT mariniarianna structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT jorematthijsm structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT søgaardmaxm structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT jørgensenthomas structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT dejonghwillema structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT sauerweinrobertw structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT longcarolea structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT biswassumi structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody
AT higginsmatthewk structuralbasisforrecognitionofthemalariavaccinecandidatepfs4845byatransmissionblockingantibody